Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study
出版年份 2023 全文链接
标题
Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study
作者
关键词
-
出版物
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-10-30
DOI
10.1111/ejh.14124
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial
- (2023) Claire N. Harrison et al. JOURNAL OF CLINICAL ONCOLOGY
- Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations
- (2022) Monia Marchetti et al. Lancet Haematology
- Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors
- (2021) Daniele Cattaneo et al. Frontiers in Immunology
- Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study
- (2017) Francesco Passamonti et al. LANCET ONCOLOGY
- Myeloproliferative Neoplasms
- (2017) Jerry L. Spivak NEW ENGLAND JOURNAL OF MEDICINE
- Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial
- (2016) S. Verstovsek et al. HAEMATOLOGICA
- Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease
- (2016) Holly Geyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial
- (2016) S. Verstovsek et al. HAEMATOLOGICA
- Current and future treatment options for polycythemia vera
- (2015) Martin Griesshammer et al. ANNALS OF HEMATOLOGY
- Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera
- (2015) Alberto Alvarez-Larrán et al. BRITISH JOURNAL OF HAEMATOLOGY
- Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
- (2015) Alessandro M. Vannucchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ruxolitinib for the treatment of patients with polycythemia vera
- (2015) Jean-Jacques Kiladjian et al. Expert Review of Hematology
- Platelet activation and inhibition in polycythemia vera and essential thrombocythemia
- (2013) C. Patrono et al. BLOOD
- Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project
- (2013) G. Barosi et al. BLOOD
- Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union
- (2013) Odile Moulard et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
- (2013) A Tefferi et al. LEUKEMIA
- ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera
- (2013) Marina Panova-Noeva et al. THROMBOSIS RESEARCH
- Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)
- (2012) T. Barbui et al. BLOOD
- Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
- (2012) Robyn M. Emanuel et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
- (2012) Roberto Marchioli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera
- (2011) A. Alvarez-Larran et al. BLOOD
- Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More